Cover Image
市場調查報告書

轉移性腦瘤:全球臨床實驗檢討

Brain Metastasis Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 296846
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
轉移性腦瘤:全球臨床實驗檢討 Brain Metastasis Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月26日 內容資訊: 英文 111 Pages
簡介

本報告提供轉移性腦瘤相關臨床研究的最新趨勢分析,以疾病概要為首,彙整主要的已開發國家·新興國家的臨床實驗狀況,各地區、各階段的進行狀況,受驗者的募集情況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • 轉移性腦瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 臨床實驗數量中南美的主要5個國家

在G7各國臨床實驗數量:佔腫瘤整體比率

在G7各國臨床實驗數量:各階段

在G7各國臨床實驗數量:各進展狀況

在E7各國臨床實驗數量:佔腫瘤整體比率

在E7各國臨床實驗數量:各階段

在E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

在各階段的實驗完成情形

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加轉移性腦瘤的治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗的最新趨勢(全5件)

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co., Inc.
    • Bayer AG
    • Pfizer Inc.
    • Novartis AG
    • AngioChem Inc.
    • Sanofi
    • Pharmacyclics, Inc.
    • AstraZeneca PLC
  • 有代表性的醫院·研究機關臨床實驗概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • Duke University
    • Radiation Therapy Oncology Group
    • Memorial Sloan Kettering Cancer Center
    • University Health Network
    • Thomas Jefferson University
    • Case Comprehensive Cancer Center
    • European Organization for Research and Treatment of Cancer

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC1998CTIDB

GlobalData's clinical trial report, "Brain Metastasis Global Clinical Trials Review, H1, 2014" provides data on the Brain Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Brain Metastasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Brain Metastasis to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Brain Metastasis to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Brain Metastasis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Brain Metastasis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Brain Metastasis
    • Nov 12, 2013: Study Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Times Greater Than Herceptin Alone
    • Apr 09, 2013: biOasis Provides Update On BT2111-Herceptin Program
    • Dec 03, 2012: Geron Discontinues Development Of Brain Cancer Drug Candidate GRN1005
    • Mar 15, 2012: Novelos Announces Enrollment Of First Patient In Brain Cancer Trial Of i-124-clr1404
    • Dec 22, 2011: Geron Initiates Phase II Trial Of GRN1005 In Brain Metastases Arising From Lung Cancer
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • AngioChem Inc.
      • Clinical Trial Overview of AngioChem Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pharmacyclics, Inc.
      • Clinical Trial Overview of Pharmacyclics, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Duke University
      • Clinical Trial Overview of Duke University
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Brain Metastasis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Brain Metastasis to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Brain Metastasis to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Brain Metastasis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Brain Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Brain Metastasis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Brain Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AngioChem Inc., 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014*
  • Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*

List of Figures

  • Brain Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Brain Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Brain Metastasis to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Brain Metastasis to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Brain Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Brain Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Brain Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top